Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-20

FDA Approved: INFED — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for INFED (iron dextran) submitted by Allergan, Inc. This action authorizes changes to the product under the supplementa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INFED (iron dextran)

Snippet

SUPPL AP for INFED (IRON DEXTRAN)